News
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
By Dennis Thompson HealthDay ReporterTUESDAY, May 6, 2025 (HealthDay News) -- The head of the U.S. Food and Drug ...
Momentum is building to scale back the current recommendation that all children over 6 months old get immunized against the ...
Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...
Columbia University and NewYork-Presbyterian Hospital agreed to pay $750 million to settle hundreds of sexual abuse claims ...
Fewer than half of Americans believe federal health agencies like the Food and Drug Administration (FDA) and the Centers for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results